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Abstract  
Vasa previa is a rare but clinically important obstetrical complication that can be associated with a low-lying placenta or placenta previa. We aim to 
present one case of vasa previa diagnosed during the placenta examination after the caesarean indicated for triple uterus scar. A 26-year-old 
female was referred to our hospital at 30 weeks of gestation to provide a scheduled caesarean. Trans-abdominal ultrasound was performed; the 
placenta was positioned in the posterior side of the fundus. Fetal growth was found to be appropriate for gestational age. A healthy male infant 
weighing was successfully delivered via cesarean section at 38 weeks of gestation. This operation helped to prevent complications due to acute 
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Introduction 
 
Vasa previa is a rare but clinically important obstetrical complication 
in which fetal blood vessels are positioned between the presenting 
part and cervix, and it can be associated with a low-lying placenta 
or placenta previa. The estimated incidence of vasa previa is 
approximately 1 in 2500 deliveries, but it is much higher (1 in 700) 
among patients who conceive through assisted reproductive 
technologies. The importance and clinical impact of an antenatal 
diagnosis of vasa previa is very significant because of the likelihood 
of adverse fetal outcomes [1]. Because the vessels are attached to 
the chorion, rupture of fetal membranes can result in fetal bleeding 
and death within minutes. When the condition is not diagnosed 
antenatally, the perinatal mortality rate is reported to be 
approximately 44%, whereas 97% of fetuses survive when an 
antenatal diagnosis is made, indicating significantly different 
outcomes [2, 3]. Furthermore, a low-lying placenta is reportedly a 
risk factor for vasa previa because it occurs in 5% of patients [4]. 
Accurate diagnosis of vasa previa is therefore crucial. Here, we 




Patient and observation 
 
A 26-year-old female (gravida 4, para 3) was referred to our 
hospital at 30 weeks of gestation to provide a scheduled caesarean. 
Trans-abdominal ultrasound was performed; the placenta was 
positioned in the posterior side of the fundus. Fetal growth was 
found to be appropriate for gestational age. The patient was 
admitted at 38 weeks of gestation to the surgery room according to 
the guidelines for the management of the uterine multiple scars. A 
healthy male infant weighing was successfully delivered via 
cesarean section, the Apgar score was 9/10/10 with no blood loss 
during delivery .The evaluation of the placenta confirmed the 
diagnosis of vasa previa (Figure 1). The postoperative course of 
the patient and the infant was uncomplicated and they were 








Previously, vasa previa was usually detected by palpation of the 
fetal vessels within the membranes during labor or on the basis of 
acute-onset vaginal bleeding and subsequent fetal bradycardia 
and/or death after membrane rupture. As discussed above, the 
importance of an accurate diagnosis of vasa previa is significant; if 
not diagnosed antenatally, the neonatal survival rate is only 44% 
with a neonatal transfusion rate of 58.5% [2]. A universal screening 
method for the detection of vasa previa has not yet been 
established [5] although high-risk factors have been identified [6]. 
Baulies et al. reported that the incidence of vasa previa was 0.07%, 
and multivariate analysis revealed the following associated factors in 
their study. In vitro fertilization (IVF) pregnancies, Therefore, if 
patients present with any of these risk factors, a concerted effort to 
detect vasa previa using ultrasound screening in the second 
trimester is necessary [7]. Screening for high-risk patients (such as 
those with IVF pregnancies, a velamentous cord, a low-lying 
placenta, low cord insertions in the uterus, or a low-lying bilobate 
placenta) has shown some success [1, 8, 9]. The primary methods 
of diagnosis are trans-vaginal ultrasonography and real-time color 
Doppler ultrasonography, and most cases are diagnosed antenatally. 
Unfortunately, in our case detailed ultrasonography in the second 
trimester for the screening of vasa previa and to detect the cord 
insertion was not performed; therefore, it was difficult to make 





We presented a case of vasa previa diagnosed postoperatively 
during caesarean scheduled for uterine multiple scars, which helped 
to prevent complications due to acute fetal bleeding. The 
identification and exclusion of vasa previa using trans-vaginal 
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Figure 1: Placenta examination showing vasa previa 
 
